abstract |
The invention relates to therapies for (auto) immune diseases. The synthesis or presence of apoptotic activity in cells that cause or are related to (auto) immune diseases, such as synoviocytes in rheumatoid arthritis, will result in the induction of apoptosis. The invention also relates to genetically distributed vehicles, comprising nucleic acid molecules encoding apoptosis-induced proteins with apoptin-like activity. |